Table 1.
Demographic and clinical variables of study groups
| Clinical measures | Healthy controls | Clinical high-risk | P-value |
|---|---|---|---|
| Number of subjects | N = 24 | N = 24 | |
| Sex (# female) | N = 13 | N = 14 | .7711 |
| Age in years (average ± SD) | 20.7 ± 4.3 (14–33) | 20.6 ± 3.9 (14–30) | .9292 |
| SOPS positive symptoms (average ± SD) | 0.083 ± 0.400 | 12.3 ± 2.9 | <.0012 |
| SOPS negative symptoms (average ± SD) | 0.125 ± 0.331 | 12.7 ± 4.4 | <.0012 |
| SOPS disorganized symptoms (average ± SD) | 0.083 ± 0.400 | 5.4 ± 1.9 | <.0012 |
| SOPS general symptoms (average ± SD) | 0.083 ± 0.276 | 7.2 ± 2.9 | <.0012 |
SD represents the standard deviation.
1Pearson Chi-Square two-sided p-value.
2Unpaired two-tailed student’s t-tests p-value.